Rangering i aksjer
#22981
W World Corp. is a biopharmaceutical firm dedicated to identifying and... W World Corp. is a biopharmaceutical firm dedicated to identifying and advancing innovative treatments for various metabolic and neurological conditions. Its research and development efforts specifically target ailments related to the brain-gut axis, pain and inflammation, autoimmune diseases, and gout. The company's pipeline features two primary experimental drugs: Levotofisopam, currently in clinical trials as a non-sedative therapy for Gout, and Dextofisopam, a non-serotonergic compound that has successfully concluded Phase IIa and Phase IIb clinical trials for irritable bowel syndrome (IBS). Established in 1990, W World Corp. maintains its corporate headquarters in North Las Vegas, Nevada.
Aksjekurs
$0.8
Sist synkronisert: 2024-01-02
Handel W World Corp. (WWHC)
Pris WWHC pris med markedsverdi på B
Markedsverdi av W World Corp.(WWHC)
Markedsverdi: $80.24M
Per August 2026 har W World Corp. en markedsverdi på $80.24M. Dette gjør W World Corp. til det 22981st mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for W World Corp. fra 1983 til 2026
WWHC sammenlignet med topp 5 mest populære stocks
| Pris på WWHC |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.211T
|
+6,494,794.51%
|
|
|
|
|
$4.547T
|
+5,666,479.39%
|
|
|
|
|
$4.162T
|
+5,187,566.21%
|
|
|
|
|
$3.593T
|
+4,477,571.27%
|
|
|
|
|
$2.793T
|
+3,480,615.83%
|
